Structural and Functional Basis of Resistance to Neuraminidase Inhibitors of Influenza B Viruses
Open Access
- 9 August 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 53 (17) , 6421-6431
- https://doi.org/10.1021/jm100621s
Abstract
We have identified a virus, B/Perth/211/2001, with a spontaneous mutation, D197E in the neuraminidase (NA), which confers cross-resistance to all NA inhibitors. We analyzed enzyme properties of the D197 and E197 NAs and compared these to a D197N NA, known to arise after oseltamivir treatment. Zanamivir and peramivir bound slowly to the wild type NA, but binding of oseltamivir was more rapid. The D197E/N mutations resulted in faster binding of all three inhibitors. Analysis of the crystal structures of D197 and E197 NAs with and without inhibitors showed that the D197E mutation compromised the interaction of neighboring R150 with the N-acetyl group, common to the substrate sialic acid and all NA inhibitors. Although rotation of the E275 in the NA active site occurs upon binding peramivir in both the D197 and E197 NAs, this does not occur upon binding oseltamivir in the E197 NA. Lack of the E275 rotation would also account for the loss of slow binding and the partial resistance of influenza B wild type NAs to oseltamivir.Keywords
This publication has 57 references indexed in Scilit:
- Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South AfricaAntiviral Research, 2009
- Pharmacokinetics of High-Dose Oseltamivir in Healthy VolunteersAntimicrobial Agents and Chemotherapy, 2009
- A Randomized, Crossover Study to Evaluate the Pharmacokinetics of Amantadine and Oseltamivir Administered Alone and in CombinationPLOS ONE, 2007
- Neuraminidase Inhibitor-Resistant and -Sensitive Influenza B Viruses Isolated from an Untreated Human PatientAntimicrobial Agents and Chemotherapy, 2006
- Scaling and assessment of data qualityActa Crystallographica Section D-Biological Crystallography, 2005
- Coot: model-building tools for molecular graphicsActa Crystallographica Section D-Biological Crystallography, 2004
- Identification of a human influenza type B strain with reduced sensitivity to neuraminidase inhibitor drugsVirus Research, 2004
- Molecular mechanisms of influenza virus resistance to neuraminidase inhibitorsVirus Research, 2004
- Refinement of Macromolecular Structures by the Maximum-Likelihood MethodActa Crystallographica Section D-Biological Crystallography, 1997
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973